Inscobee Inc. - Significant Ownership

Signature - Title
/s/ Jakap Koo - Jakap Koo, Chief Executive Officer
Location
Seoul, Korea, Republic of
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Inscobee Inc..

Notify me when Inscobee Inc. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Inscobee Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Apimeds Pharmaceuticals US, Inc. Common Stock 37.9% 4.39M Apimeds Inc. May 12, 2025

Schedules 13D/G Reported by Inscobee Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.